Broadwater Capital’s Idexx Laboratories IDXX Stock Holding History

Broadwater Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-800	Closed	-$444K	–	237
2023 Q4	$444K	Buy	+800	New	+$376K	0.35%	55

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Broadwater Capital's IDXX Position: Q1 2024 in Review

Broadwater Capital sold out of Idexx Laboratories (IDXX) in Q1 2024, closing a stake of 800 shares — an estimated $444K sold.

Broadwater Capital first reported a position in IDXX in Q4 2023 and held it in 1 quarter. The position peaked at $444K in Q4 2023. 1,149 funds tracked by Wall St. Rank hold IDXX as of Q1 2024.

Broadwater Capital reported no remaining Idexx Laboratories position as of Q1 2024 after selling out during the quarter.
Broadwater Capital sold 800 Idexx Laboratories shares in Q1 2024, an estimated $444K.
Broadwater Capital first reported a position in Idexx Laboratories in Q4 2023 and held it in 1 quarter.
Broadwater Capital's Idexx Laboratories position peaked at $444K in Q4 2023.
1,149 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2024.

Based on Broadwater Capital's 13F filing for Q1 2024, filed 31 Oct 2025.